Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Mecánica aplicada
18
Estática
16
Dinámica
6
Literatura rusa
6
Análisis vectorial
5
Crítica e interpretación
5
Historia y crítica
4
Poesía rusa
4
Resistencia de materiales
4
Mecánica de fluidos
3
Problemas, ejercicios, etc
3
Teoría de las estructuras
3
Aerodinámica
2
Autores rusos
2
Canciones folklóricas mexicanas
2
Canciones infantiles
2
Control de vuelo
2
Cultura
2
Ensayos rusos
2
Estudio y enseñanza
2
Indígenas de México
2
Ingeniería mecánica
2
Modelos matemáticos
2
Método de elementos finitos
2
Novela hispanoamericana
2
Poesía colombiana
2
Poesía congoleña (Brazzaville)
2
Positivismo lógico
2
Robótica
2
Vida intelectual
2
-
37741“…Resulting quantitative data was analysed using the Statical Package for Social Sciences (SPSS) and qualitative data was analysed using grounded theory techniques. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37742por Borgermans, Liesbeth, Goderis, Geert, Broeke, Carine Van Den, Mathieu, Chantal, Aertgeerts, Bert, Verbeke, Geert, Carbonez, An, Ivanova, Anna, Grol, Richard, Heyrman, Jan“…Secondary endpoints are individual improvements in 12 validated parameters: glycosylated hemoglobin, low and high density lipoprotein/cholesterol, total cholesterol, systolic blood pressure, diastolic blood pressure, weight, physical exercise, healthy diet, smoking status, and statin and anti-platelet therapy. PRIMARY AND SECONDARY ANALYSIS: Statistical analyses will be performed using an intent-to-treat approach with a multilevel model. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37743por Regieli, Jakub J., Jukema, J. Wouter, Doevendans, Pieter A., Zwinderman, Aeilko H., van der Graaf, Yolanda, Kastelein, John J., Grobbee, Diederick E.“…RESEARCH DESIGN AND METHODS: The Regression Growth Evaluation Statin Study (REGRESS) cohort was genotyped for the Pro12Ala variant (rs1801282). …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37744por Sattar, Naveed, Murray, Heather M., Welsh, Paul, Blauw, Gerard J., Buckley, Brendan M., Cobbe, Stuart, de Craen, Anton J. M., Lowe, Gordon D., Jukema, J. Wouter, Macfarlane, Peter W., Murphy, Michael B., Stott, David J., Westendorp, Rudi G. J., Shepherd, James, Ford, Ian, Packard, Chris J.“…The results were also similar in placebo and statin recipients (i.e., no interaction). The C-statistic for fatal CVD using traditional risk factors was significantly (+0.017; p<0.0001) improved by inclusion of IL-6 but not so for nonfatal CVD events (p = 0.20). …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37745“…In multivariate analysis, significant predictors of CKD documentation were eGFR, hypertension, type 2 diabetes, congestive heart failure, peripheral artery disease, statin use, age and gender. CKD documentation was lower among women than similarly affected men. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37746por Flather, Marcus D, Booth, Jean, Babalis, Daphne, Bueno, Hector, Steg, Philippe G, Opolski, Grzegorz, Ottani, Filippo, Machecourt, Jacques, Bardaji, Alfredo, Bojestig, Mats, Brady, Anthony R, Lindahl, Bertil“…The primary outcome is a composite of eight measures to assess aggregate potential for improvement in the management and treatment of this patient population (risk stratification, early coronary angiography, anticoagulation, beta-blockers, statins, ACE-inhibitors, clopidogrel as a loading dose and at discharge). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37747por Carlzon, Daniel, Gustafsson, Lena, Eriksson, Anna L, Rignér, Karin, Sundström, Anders, Wallerstedt, Susanna M“…A national sales register for prescribed drugs (Xplain) was used for evaluation of adherence to the six regional prescribing objectives concerning proton pump inhibitors (PPIs), angiotensin converting enzyme inhibitors (ACEIs), statins and antidepressants. RESULTS: Twenty-two out of 25 primary health care units responded to the questionnaire (response rate 88%). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37748por McCracken, John, Baccarelli, Andrea, Hoxha, Mirjam, Dioni, Laura, Melly, Steve, Coull, Brent, Suh, Helen, Vokonas, Pantel, Schwartz, Joel“…We found evidence of effect modification, with a stronger association among subjects ≥ 75 years of age compared with younger participants (p = 0.050) and statin medications appearing protective of the effects of BC on LTL (p = 0.050). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37749por Insull, William, Toth, Peter P, Superko, H Robert, Thakkar, Roopal B, Krause, Scott, Jiang, Ping, Parreno, Rhea A, Padley, Robert J“…PATIENTS AND METHODS: Patients (n = 137) with dyslipidemia (not previously receiving statin therapy or having discontinued any lipid-altering treatment 4–5 weeks prior to the study) received NER/S (1000/40 mg/day for four weeks, then 2000/40 mg/day for eight weeks) or atorvastatin 40 mg/day for 12 weeks. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37750por Herring, Neil, Lee, Chee Wan, Sunderland, Nicholas, Wright, Kathryn, Paterson, David J.“…Hypertension is associated with heightened cardiac sympathetic drive whilst statins reduce angiotensin II (ATII) signalling, superoxide anion production and increase nitric oxide bioavailability, events that can potentially reduce peripheral cardiac sympathetic neurotransmission. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37751por Benhamou, Simon“…BACKGROUND: Although habitat use reflects a dynamic process, most studies assess habitat use statically as if an animal's successively recorded locations reflected a point rather than a movement process. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37752por Li, Hung-Yuan, Jiang, Yi-Der, Chang, Tien-Jyun, Wei, Jung-Nan, Lin, Mao-Shin, Lin, Cheng-Hsin, Chiang, Fu-Tien, Shih, Shyang-Rong, Hung, Chi Sheng, Hua, Cyue-Huei, Smith, David J., Vanio, Jani, Chuang, Lee-Ming“…Subjects with serum VAP-1 in the highest tertile had a hazard ratio (HR) of 2.19 (95% CI 1.17–4.11) for all-cause mortality adjusted for age, sex, smoking, history of cardiovascular disease, obesity, hypertension, hemoglobin A(1c), diabetes duration, total cholesterol, use of statins, abnormal ankle-brachial index, estimated glomerular filtration rate (eGFR), and proteinuria. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37753por Dalan, Rinkoo, Jong, Michelle, Chan, Siew-Pang, Hawkins, Robert, Choo, Robin, Lim, Brenda, Tan, May L, Leow, Melvin KS“…Indians had higher hs-CRP when compared to Chinese (P < 0.05) and a significant correlation was seen between BMI, female gender, diabetes, and the use of metformin and hs-CRP in all three ethnicities (P < 0.05) when adjusted for the above variables and use of aspirin, angiotensin-converting enzyme inhibitor/angiotensin receptor blockers (ACE-I/ARB), statin, metformin, rosiglitazone, sulfonylurea, glinides, acarbose, and insulin. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Texto -
37754“…One way analysis of variance was used for statics application RESULTS: Serum levels of selected liver protein and enzymes were significantly increased in the combination of MSC and HGF-CNP (MSC+HGF-CNP) treated group. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
37755“…In an receiver operating characteristic analysis, fair discrimination for CIN was found at a g-I/eGFR level of 1.42 (C statics=0.867), and at this value, the sensitivity and specificity were 81.3% and 80%, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
37756por Ramos, Silvia C, Fonseca, Francisco A, Kasmas, Soraia H, Moreira, Flávio T, Helfenstein, Tatiana, Borges, Ney C, Moreno, Ronilson A, Rezende, Vinicius M, Silva, Fernanda C, Izar, Maria C“…BACKGROUND: It has been demonstrated that statins can increase intestinal sterol absorption. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
37757por Empen, Klaus, Frost, Robert JA, Geiss, H Christian, Otto, Carsten, Parhofer, Klaus G“…It is unclear whether fibrate or statin therapy has more beneficial effects on adhesion molecule concentrations. …”
Publicado 2003
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
37758por da Silva, Renata Juliana, Bernardes, Nathalia, de O. Brito, Janaina, Sanches, Iris Callado, Irigoyen, Maria Cláudia, De Angelis, Kátia“…These results support the hypothesis that statins reduce the cardiometabolic risk in females with metabolic syndrome.…”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
37759por Butala, Neel M., Desai, Mayur M., Linnander, Erika L., Wong, Y. Rex, Mikhail, Daoud G., Ott, Lesli S., Spertus, John A., Bradley, Elizabeth H., Aaty, Ahmed Abdel, Abdelfattah, Alia, Gamal, Ayman, Kholeif, Hatem, Baz, Mohamed El, Allam, A. H., Krumholz, Harlan M.“…Women were less likely to receive aspirin upon admission (p<0.01) or aspirin or statins at discharge (p = 0.001 and p<0.05, respectively), although the magnitude of these differences was small. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
37760por Hamer, Mark, Endrighi, Romano, Venuraju, Shreenidhi M., Lahiri, Avijit, Steptoe, Andrew“…There was an association between cortisol stress reactivity (per SD) and CAC progression (odds ratio = 1.27, 95% CI, 1.02–1.60) after adjustments for age, sex, pre-stress cortisol, employment grade, smoking, resting systolic BP, fibrinogen, body mass index, and use of statins. There was no association between systolic blood pressure reactivity and CAC progression (odds ratio per SD increase = 1.03, 95% CI, 0.85–1.24). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto